Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Pruess TH"'
Autor:
Smith MD; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA. misty.smith@pharm.utah.edu.; School of Dentistry, University of Utah, Salt Lake City, 84112, USA. misty.smith@pharm.utah.edu., Woodhead JH; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Handy LJ; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Pruess TH; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Vanegas F; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Grussendorf E; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Grussendorf J; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., White K; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Bulaj KK; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Krumin RK; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Hunt M; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA., Wilcox KS; Epilepsy Therapy Screening Program Contract Site, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84108, USA.
Publikováno v:
Neurochemical research [Neurochem Res] 2017 Jul; Vol. 42 (7), pp. 1995-2010. Date of Electronic Publication: 2017 May 15.
Autor:
Barker-Haliski ML; Department of Pharmacy, University of Washington, Seattle, WA, 98195, USA. mhaliski@uw.edu., Johnson K; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Billingsley P; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Huff J; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Handy LJ; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Khaleel R; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Lu Z; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Mau MJ; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Pruess TH; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Rueda C; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Saunders G; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Underwood TK; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Vanegas F; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA., Smith MD; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA.; Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84112, USA., West PJ; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA.; Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84112, USA., Wilcox KS; Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA.; Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84112, USA.
Publikováno v:
Neurochemical research [Neurochem Res] 2017 Jul; Vol. 42 (7), pp. 1904-1918. Date of Electronic Publication: 2017 Mar 16.
Autor:
Barker-Haliski ML; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A.; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, U.S.A., Heck TD; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A., Dahle EJ; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A., Vanegas F; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A., Pruess TH; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A., Wilcox KS; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A., White HS; Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, U.S.A.; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, U.S.A.
Publikováno v:
Epilepsia [Epilepsia] 2016 Dec; Vol. 57 (12), pp. 1958-1967. Date of Electronic Publication: 2016 Oct 14.
Autor:
Barker-Haliski ML; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah melissa.barker@utah.edu., Dahle EJ; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah., Heck TD; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah., Pruess TH; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah., Vanegas F; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah., Wilcox KS; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah., White HS; Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2015 May; Vol. 353 (2), pp. 318-29. Date of Electronic Publication: 2015 Mar 09.
Autor:
Robertson CR; Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84108, USA. charles.robertson@utah.edu, Pruess TH, Grussendorf E, White HS, Bulaj G
Publikováno v:
ChemMedChem [ChemMedChem] 2012 May; Vol. 7 (5), pp. 903-9. Date of Electronic Publication: 2012 Feb 28.
Autor:
Green BR; Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City, UT 84108, USA., White KL, McDougle DR, Zhang L, Klein B, Scholl EA, Pruess TH, White HS, Bulaj G
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society [J Pept Sci] 2010 Sep; Vol. 16 (9), pp. 486-95.
Autor:
Singh NA; Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America. nsingh@genetics.utah.edu, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J, Dixon M, Gurnett C, Peiffer A, White HS, Filloux F, Leppert MF
Publikováno v:
PLoS genetics [PLoS Genet] 2009 Sep; Vol. 5 (9), pp. e1000649. Date of Electronic Publication: 2009 Sep 18.
Autor:
White HS; Department of Pharmacology, College of Pharmacy, University of Utah, Salt Lake City, Utah 84108, USA. swhite@hsc.utah.edu, Scholl EA, Klein BD, Flynn SP, Pruess TH, Green BR, Zhang L, Bulaj G
Publikováno v:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2009 Apr; Vol. 6 (2), pp. 372-80.